Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-Blind, Randomized, Placebo-Controlled, Multi-Center Trial to Evaluate the Efficacy and Safety of Tranexamic Acid in Adult Liver Transplantation (ESTA Trial)

NCT07157631 is registered in ClinicalTrials.gov with RenJi Hospital as lead sponsor.

NCT NCT07157631
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07157631 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-Blind, Randomized, Placebo-Controlled, Multi-Center Trial to Evaluate the Efficacy and Safety of Tranexamic Acid in Adult Liver Transplantation (ESTA Trial)
Lead sponsor
RenJi Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
November 1, 2025
Completion date
December 1, 2027
Enrollment
1,546 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

end-stage liver disease (esld), liver transplantation, tranexamic acid